B.C. Reg. 281/2008
M241/2008
Deposited October 15, 2008
effective October 17, 2008
This consolidation is current to March 5, 2024.
Link to consolidated regulation (PDF)
Link to Point in Time
Health Professions Act
Midwives Regulation
[Last amended September 1, 2020 by B.C. Reg. 167/2020]
Definitions
1
In this regulation:
"Act"
means the
Health Professions Act
;
"compound"
means to mix with one or more other ingredients;
"dispense"
has the same meaning as in the
Pharmacy Operations and Drug Scheduling Act
, but excludes a sale as defined in that Act;
"Drug Schedules Regulation"
means the Drug Schedules Regulation, B.C. Reg. 9/98;
"hospital"
has the same meaning as in the
Hospital Act
;
"Indigenous"
means relating to the aboriginal peoples of Canada within the meaning
of section 35 of the
Constitution Act
, 1982;
"Indigenous midwifery"
means
(a)
traditional Indigenous midwifery practices including the use and
administration of traditional herbs and medicines and other cultural
and spiritual practices,
(b)
contemporary Indigenous midwifery practices which are based on, or
originate in, traditional Indigenous midwifery practices, or
(c)
a combination of traditional and contemporary Indigenous midwifery
practices;
"midwifery"
means the health profession in which a person provides the following
services during normal pregnancy, labour, delivery and the postpartum
period:
(a)
assessment, monitoring and care for patients, newborns and infants,
including carrying out appropriate emergency measures when necessary;
(b)
counselling, supporting and advising persons, including providing
advice and information regarding care for newborns and infants;
(c)
conducting internal examinations of patients, performing episiotomies
and amniotomies and repairing episiotomies and simple lacerations;
(d)
contraceptive services for patients during the 3 months following a
birth;
"midwifery diagnosis"
means a clinical judgment of a patient's mental or physical condition,
or that of the patient's newborn, to determine whether
(a)
the condition can be ameliorated or resolved by services that the
registrant is authorized to provide, or
(b)
consultation with, or transfer of responsibility for care to, another
health professional is necessary or appropriate;
"narcotic"
has the same meaning as in the Narcotic Control Regulations made under
the
Controlled Drugs and Substances Act
(Canada);
"parenteral instillation"
means instillation directly into the blood stream;
"patient"
means a person who
(a)
is pregnant,
(b)
is in labour or is delivering a child, or
(c)
is in the postpartum period;
"prescribe"
means to issue a prescription as defined in the
Pharmacy Operations and Drug Scheduling Act
, except a prescription issued in respect of an animal;
"registrant"
means a registrant who is authorized under the bylaws to practise
midwifery;
"reserve"
means a reserve as defined in the
Indian Act
(Canada);
"substance"
includes air and water, but excludes
(a)
a drug specified in Schedule I, IA, II or IV of the Drug Schedules
Regulation, and
(b)
Repealed. [B.C. Reg. 274/2016, s. 1 (c).]
[am. B.C. Regs. 155/2009, s. 1; 274/2016, s. 1; 167/2020, Sch. 1, s.
1.]
College name
2
The name of the college responsible for carrying out the objects of
the Act in respect of midwifery is "British Columbia College of Nurses
and Midwives".
[en. B.C. Reg. 167/2020, Sch. 1, s. 2.]
Reserved title
3
The title "midwife" is reserved for exclusive use by registrants.
Scope of practice
4
(1)
A registrant may practise midwifery.
(2)
A registrant who is Indigenous may practise Indigenous midwifery.
[en. B.C. Reg. 155/2009, s. 2; am. B.C. Reg. 167/2020, Sch. 1, s. 3.]
Provisional registrant classes
4.1
The college is authorized to establish, under section 19 (1) (i) of
the Act, a class of provisional registrants for the purposes of
section 20 (4.3) of the Act.
[en. B.C. Reg. 167/2020, Sch. 1, s. 4.]
Restricted activities
5
(1)
A registrant in the course of practicing midwifery may do any of the
following:
(a)
make a midwifery diagnosis identifying a condition as the cause of
signs or symptoms of an individual;
(b)
perform a procedure on tissue below the dermis or below the surface of
a mucous membrane, for the purposes of
(i)
performing episiotomies or amniotomies,
(ii)
repairing episiotomies or simple lacerations, or
(iii)
taking a swab or specimen required for a screening or diagnostic test;
(c)
insert acupuncture needles under the skin for the purpose of pain
relief during labour or the postpartum period;
(d)
for the purpose of collecting a blood sample, perform venipuncture;
(e)
for the purpose of wound care during the postpartum period, administer
a solution by irrigation;
(f)
administer a substance by
(i)
injection,
(ii)
inhalation, or
(iii)
parenteral instillation
for the purposes of
(iv)
pain relief,
(v)
preventing or treating dehydration or blood loss,
(vi)
resuscitation or other emergency measures, or
(vii)
other purposes as required for midwifery practice;
(g)
put an instrument or a hand or finger
(i)
beyond the point in the nasal passages where they normally narrow, for
the purpose of suctioning a newborn,
(ii)
beyond the pharynx, for the purpose of intubating a newborn,
(iii)
beyond the opening of the urethra, for the purpose of catheterization
of a patient during labour or the postpartum period,
(iv)
beyond the labia majora, for the purposes of
(A)
conducting internal examinations of patients,
(B)
performing episiotomies or amniotomies,
(C)
repairing episiotomies or simple lacerations, or
(D)
conducting the vacuum-assisted emergency delivery of a baby,
(v)
beyond the anal verge, for the purposes of
(A)
assessing perineal repairs,
(B)
administering a substance, or
(C)
assisting in the emergency delivery of a baby, or
(vi)
into an artificial opening into the body, for the purpose of assisting
in the surgical delivery of a baby;
(h)
manage labour or normal, spontaneous vaginal delivery of a baby;
(i)
apply ultrasound for the purpose of fetal heart monitoring;
(j)
give an instruction or authorization for another person to apply, to a
named individual, ultrasound for diagnostic or imaging purposes,
including any application of ultrasound to a fetus;
(k)
in respect of a drug specified in Schedule I or IA of the Drug
Schedules Regulation that is prescribed by a medical practitioner or a
nurse practitioner,
(i)
compound the drug,
(ii)
dispense the drug, or
(iii)
administer the drug by any method;
(l)
in respect of a drug specified in Schedule I or IA of the Drug
Schedules Regulation,
(i)
prescribe the drug,
(ii)
compound the drug,
(iii)
dispense the drug, or
(iv)
administer the drug by any method;
(m)
in respect of a drug specified in Schedule II of the Drug Schedules
Regulation,
(i)
prescribe the drug,
(ii)
compound the drug,
(iii)
dispense the drug, or
(iv)
administer the drug by any method.
(1.1)
Only a registrant may provide a service that includes the performance
of an activity set out in subsection (1).
(2)
Subsection (1.1) does not apply on a reserve to an Indigenous person
who practised Indigenous midwifery prior to March 15, 1995.
[am. B.C. Regs. 155/2009, s. 3; 274/2016, s. 2; 167/2020, Sch. 1, s.
5.]
Limits or conditions on services and restricted activities
6
(1)
A registrant must consult with a medical practitioner or nurse
practitioner regarding any deviations from the normal course of
pregnancy, labour, delivery and the postpartum period that indicate
pathology and transfer responsibility for care to another health
professional when necessary or appropriate.
(2)
A registrant may provide a service that includes the performance of an
activity described in section 5 (1) (c),
(g) (iv) (D) or (vi) or (l) only if the registrant
has successfully completed a certification program established,
required or approved under the bylaws to ensure registrants are
qualified and competent to provide the service and perform the
activity.
(3)
A registrant may perform an activity described in section
5 (1) (k) only after consulting with a medical practitioner
or a nurse practitioner, unless the registrant is authorized under
section 5 (1) (l) and subsection (4) of this section to
perform the activity.
(4)
A registrant may perform an activity described in
section 5 (1) (l) in respect of a drug included in a
category of drugs set out in
(a)
Column 1 of Schedule A, only for a purpose shown opposite in
Column 2 of Schedule A, and
(b)
Column 1 of Schedule B, only for a purpose shown opposite in
Column 2 of Schedule B.
(5)
Repealed. [B.C. Reg. 274/2016, s. 3 (d).]
(6)
A registrant may perform an activity described in section 5 (1) (k) to
(m) only in respect of a patient or the patient's newborn, as the case
may be, during pregnancy, labour, delivery or the postpartum period.
[en. B.C. Reg. 155/2009, s. 4; am. B.C. Regs. 274/2016, s. 3;
167/2020, Sch. 1, s. 6.]
Patient relations program
7
The college is designated for the purposes of
section 16 (2) (f) of the Act.
Schedules 1 and 2
Repealed. [B.C. Reg. 155/2009, s. 5.]
Schedule A
[en. B.C. Reg. 155/2009, s. 5; am. B.C. Regs. 274/2016, s. 4;167/2020,
Sch. 1, s. 7.]
Column 1
Category Description
Column 2
Purposes
Antibiotics
intra-partum chemoprophylaxis for Group B strep
treatment of topical infection
treatment of breast infection
treatment of urinary tract infection
prophylaxis of ophthalmia neonatorum
Anaesthetics
performance of episiotomies
repair of episiotomies and lacerations
treatment of topical inflammation
localized pain prophylaxis
Anti-coagulants
prophylaxis of venous thromboembolism
Anti-fungals
treatment of candidiasis
Anti-nauseants / Anti-emetics
treatment of nausea and vomiting
Anti-virals
suppression of viral infections during pregnancy
and the postpartum period, excluding HIV/AIDS
management
Benzodiazepines
therapeutic rest in prodromal labour short term management of
excessive anxiety in the postpartum period
Corticosteroids
treatment of skin inflammation and haemorrhoids
Galactagogues
enhancement of breast milk production
Histamine antagonists
treatment of anaphylaxis related to the administration of drugs,
vaccines or sera
Immune globulins
prophylaxis in the neonate
prophylaxis or treatment of the patient in pregnancy
or the postpartum period
Inhalants
pain relief in labour or the immediate postpartum period
Narcotic antagonists
reversal of narcotic-induced depression
Narcotics
pain relief in labour or the postpartum period
Nitrates
treatment of hypertonic uterine contractions with non-reassuring
fetal status
Non-steroidal anti-inflammatories
relief of inflammation and pain
Sympathomimetics
treatment of anaphylaxis or allergic reaction following
the administration of a drug, vaccine or serum
neonatal resuscitation
Uterotonic agents
prophylaxis and treatment of uterine atony and postpartum
haemorrhage
Vaccines
establishing an immune response
Vitamin and mineral supplements
nutritional therapy and support
Schedule B
[en. B.C. Reg. 155/2009, s. 5.]
Column 1
Category Description
Column 2
Purposes
Antibiotics
treatment of infection not included in Schedule A
Anti-virals
HIV/AIDS management
Cervical ripening agents
induction of labour
Contraceptives
prevention of conception
Epidural analgesia (continuous infusion maintenance)
pain relief during labour and delivery, in a hospital only
Oxytocin (intravenous infusion)
induction or augmentation of labour, in a hospital only
[Provisions relevant to the enactment of this regulation:
Health Professions Act
, R.S.B.C. 1996, c. 183, s. 12 (2).]
